Therapeutic modulation of retinoid X receptors – SAR and therapeutic potential of RXR ligands and recent patents
出版年份 2019 全文链接
标题
Therapeutic modulation of retinoid X receptors – SAR and therapeutic potential of RXR ligands and recent patents
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 29, Issue 8, Pages 605-621
出版商
Informa UK Limited
发表日期
2019-07-12
DOI
10.1080/13543776.2019.1643322
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype
- (2019) Pascal Heitel et al. ACS Medicinal Chemistry Letters
- Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
- (2019) Julius Pollinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Alternative retinoid X receptor (RXR) ligands
- (2019) Wojciech Krężel et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Emerging roles of bexarotene in the prevention, treatment and anti-drug resistance of cancers
- (2018) Danyang Shen et al. Expert Review of Anticancer Therapy
- Computer-Assisted Discovery of Retinoid X Receptor Modulating Natural Products and Isofunctional Mimetics
- (2018) Daniel Merk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Opportunities and Challenges for Fatty Acid Mimetics in Drug Discovery
- (2017) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s disease
- (2017) Athanasios D. Spathis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Endogenous Mammalian Retinoid X Receptor Ligand, At Last!
- (2016) Ángel R. de Lera et al. ChemMedChem
- Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors
- (2016) Lisi Qi et al. CURRENT DRUG METABOLISM
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- Nitrostyrene Derivatives Act as RXR Ligands to Inhibit TNF Activation of NF- B
- (2015) Z. Zeng et al. CANCER RESEARCH
- Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment
- (2015) Daniel Merk Future Medicinal Chemistry
- Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers
- (2015) Venkatram R. Atigadda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nuclear receptor full-length architectures: confronting myth and illusion with high resolution
- (2015) Fraydoon Rastinejad et al. TRENDS IN BIOCHEMICAL SCIENCES
- Effect of NKG2D ligand expression on host immune responses
- (2015) Marine Champsaur et al. IMMUNOLOGICAL REVIEWS
- Retinoid X receptor ligands: a patent review (2007 – 2013)
- (2014) Shoya Yamada et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Methyl Substitution of a Rexinoid Agonist Improves Potency and Reveals Site of Lipid Toxicity
- (2014) Venkatram R. Atigadda et al. JOURNAL OF MEDICINAL CHEMISTRY
- Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
- (2013) Rosana Álvarez et al. CHEMICAL REVIEWS
- Defining the Communication between Agonist and Coactivator Binding in the Retinoid X Receptor α Ligand Binding Domain
- (2013) LeeAnn J. Boerma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic Acid (CD3254)
- (2013) Peter W. Jurutka et al. JOURNAL OF MEDICINAL CHEMISTRY
- ApoE-Directed Therapeutics Rapidly Clear -Amyloid and Reverse Deficits in AD Mouse Models
- (2012) P. E. Cramer et al. SCIENCE
- Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
- (2012) Yang Hong-Qi et al. Translational Neurodegeneration
- Modulation of RXR function through ligand design
- (2011) Efrén Pérez et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Structure Basis of Bigelovin as a Selective RXR Agonist with a Distinct Binding Mode
- (2011) Haitao Zhang et al. JOURNAL OF MOLECULAR BIOLOGY
- Molecular Determinants of Magnolol Targeting Both RXRα and PPARγ
- (2011) Haitao Zhang et al. PLoS One
- Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor
- (2010) Haitao Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a Naturally Occurring Rexinoid, Honokiol, That Activates the Retinoid X Receptor
- (2010) Hitoshi Kotani et al. JOURNAL OF NATURAL PRODUCTS
- Retinoid X receptor gamma signaling accelerates CNS remyelination
- (2010) Jeffrey K Huang et al. NATURE NEUROSCIENCE
- Modulating Retinoid X Receptor with a Series of (E)-3-[4-Hydroxy-3-(3-alkoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)phenyl]acrylic Acids and Their 4-Alkoxy Isomers†
- (2009) Efrén Pérez Santín et al. JOURNAL OF MEDICINAL CHEMISTRY
- Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene)
- (2009) Carl E. Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- The First Potent Subtype-Selective Retinoid X Receptor (RXR) Agonist Possessing a 3-Isopropoxy-4-isopropylphenylamino Moiety, NEt-3IP (RXRα/β-dual agonist)
- (2008) Kayo Takamatsu et al. ChemMedChem
- Pathophysiology, Clinical Presentation, and Management of Colon Cancer
- (2008) Mitchell S. Cappell GASTROENTEROLOGY CLINICS OF NORTH AMERICA
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now